Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors

Bosman, 2010, 13 Rindi, 2012, TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study, J Natl Cancer Inst, 104, 764, 10.1093/jnci/djs208 Essand, 2011, Oncolytic viruses for the treatment of neuroendocrine tumors, Horm Metab Res, 43, 877, 10.1055/s-0031-1277225 Rindi, 2012, Neuroendocrine neoplasms of the gut and pancreas: new insights, Nat Rev Endocrinol, 8, 54, 10.1038/nrendo.2011.120 Cunningham, 2011, Common pathogenetic mechanism involving human chromosome 18 in familial and sporadic ileal carcinoid tumors, Genes Chromosomes Cancer, 50, 82, 10.1002/gcc.20834 Cunningham, 2011, The biological hallmarks of ileal carcinoids, Eur J Clin Invest, 41, 1353, 10.1111/j.1365-2362.2011.02537.x Essand, 2005, Identification and characterization of a novel splicing variant of vesicular monoamine transporter 1, J Mol Endocrinol, 35, 489, 10.1677/jme.1.01875 Leja, 2007, A novel chromogranin-A promoter-driven oncolytic adenovirus for midgut carcinoid therapy, Clin Cancer Res, 13, 2455, 10.1158/1078-0432.CCR-06-2532 Leja, 2011, Oncolytic adenovirus modified with somatostatin motifs for selective infection of neuroendocrine tumor cells, Gene Therapy, 18, 1052, 10.1038/gt.2011.54 Vikman, 2008, CD8+ T cells against multiple tumor-associated antigens in peripheral blood of midgut carcinoid patients, Cancer Immunol Immunother, 57, 399, 10.1007/s00262-007-0382-4 Cui, 2010, Paraneoplastic antigen Ma2 autoantibodies as specific blood biomarkers for detection of early recurrence of small intestine neuroendocrine tumors, PLoS One, 5, e16010, 10.1371/journal.pone.0016010 Leja, 2009, Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas, Mod Pathol, 22, 261, 10.1038/modpathol.2008.174 Garzon, 2010, Targeting microRNAs in cancer: rationale, strategies and challenges, Nat Rev Drug Discov, 9, 775, 10.1038/nrd3179 Bartel, 2004, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5 Bartel, 2004, Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs, Nat Rev Genet, 5, 396, 10.1038/nrg1328 Sakamoto, 2009, The NF90-NF45 complex functions as a negative regulator in the microRNA processing pathway, Mol Cell Biol, 29, 3754, 10.1128/MCB.01836-08 Zhong, 2012, miRNAs in human cancer, Methods Mol Biol, 822, 295, 10.1007/978-1-61779-427-8_21 Brown, 2009, Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications, Nat Rev Genet, 10, 578, 10.1038/nrg2628 Lee, 2012, Altered expression of microRNA miR-21, miR-155, and let-7a and their roles in pulmonary neuroendocrine tumors, Pathol Int, 62, 583, 10.1111/j.1440-1827.2012.02845.x Markou, 2011, Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer, Clin Chem Lab Med, 49, 1591, 10.1515/CCLM.2011.661 Voortman, 2010, Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors, Proc Natl Acad Sci USA, 107, 13040, 10.1073/pnas.1008132107 Ruebel, 2010, MicroRNA expression in ileal carcinoid tumors: downregulation of microRNA-133a with tumor progression, Mod Pathol, 23, 367, 10.1038/modpathol.2009.161 Gao, 2011, Tissue-specific regulation of mouse microRNA genes in endoderm-derived tissues, Nucleic Acids Res, 39, 454, 10.1093/nar/gkq782 Saeed, 2006, TM4 microarray software suite, Methods Enzymol, 411, 134, 10.1016/S0076-6879(06)11009-5 Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method, Methods, 25, 402, 10.1006/meth.2001.1262 Nakamura, 2007, Laser capture microdissection for analysis of single cells, Methods Mol Med, 132, 11, 10.1007/978-1-59745-298-4_2 Lewis, 2005, Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets, Cell, 120, 15, 10.1016/j.cell.2004.12.035 Allegra, 2012, Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (Review), Int J Oncol, 41, 1897, 10.3892/ijo.2012.1647 You, 2012, Cancer genetics and epigenetics: two sides of the same coin?, Cancer Cell, 22, 9, 10.1016/j.ccr.2012.06.008 Braun, 2007, Enterochromaffin cells of the human gut: sensors for spices and odorants, Gastroenterology, 132, 1890, 10.1053/j.gastro.2007.02.036 Leu, 2010, GPCR somatostatin receptor extracellular loop 2 is a key ectodomain for making subtype-selective antibodies with agonist-like activities in the pancreatic neuroendocrine tumor BON cell line, Pancreas, 39, 1155, 10.1097/MPA.0b013e3181de8c05 Millar, 2010, The year in G protein-coupled receptor research, Mol Endocrinol, 24, 261, 10.1210/me.2009-0473 Woehler, 2009, G protein-mediated signaling: same receptor, multiple effectors, Curr Mol Pharmacol, 2, 237, 10.2174/1874467210902030237 Kaku, 1980, Establishment of a carcinoembryonic antigen-producing cell line from human pancreatic carcinoma, Gann, 71, 596 Cui, 2012, Olfactory receptor 51E1 is a potential novel tissue biomarker for the diagnosis and prognosis of small intestine neuroendocrine tumors, Regul Pept, 177, S18, 10.1016/j.regpep.2012.05.027 Hamfjord, 2012, Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencing, PLoS One, 7, e34150, 10.1371/journal.pone.0034150 Heneghan, 2010, MiRNAs as biomarkers and therapeutic targets in cancer, Curr Opin Pharmacol, 10, 543, 10.1016/j.coph.2010.05.010 Roldo, 2006, MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior, J Clin Oncol, 24, 4677, 10.1200/JCO.2005.05.5194 Cortez, 2011, MicroRNAs in body fluids—the mix of hormones and biomarkers, Nat Rev Clin Oncol, 8, 467, 10.1038/nrclinonc.2011.76